Showing 161-170 of 328 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| Treating Type 1 Diabetes: Role of Kisspeptin | Rutgers Biomedical and Health Sciences | Moshmi Bhattacharya | Cures | 01-April-2024 to 31-March-2026 | $140.000,00 |
| Defining the role of islet-derived extracellular vesicle PD-L1 cargo in type-1 diabetes | Trustees of Indiana University | Chaitra Rao | Cures | 01-March-2024 to 30-April-2027 | $228.537,45 |
| Leveraging Real-Time Insulin Sensitivity Estimation for the Adaptation of a Fully-Closed Loop Automated Insulin Delivery System to Improve Glycemic Control in Adolescents with Type 1 Diabetes | Rector & Visitors of the University of Virginia | H. Marcela Moscoso Vasquez | Improving Lives | 01-April-2024 to 31-March-2026 | $189.709,00 |
| Bcl6 and the B/Tfh axis in type 1 diabetes pathogenesis | Vanderbilt University Medical Center (VUMC) | Dudley McNitt | Cures | 01-March-2024 to 28-February-2027 | $265.320,00 |
| JDRF Cures Patient Preference Study in Type 1 Diabetes | RTI International | Kelley Myers | Transportfolio | 01-July-2023 to 30-June-2026 | $831.600,00 |
| Sensor for early detection of immune activation in diabetes | Regents of the University of Michigan | Lonnie Shea | Cures | 01-January-2024 to 31-December-2025 | $300.000,00 |
| Cell capture scaffold to monitor islet transplant rejection | Regents of the University of Michigan | Lonnie Shea | Cures | 01-September-2023 to 28-February-2026 | $600.000,00 |
| Cooperative harmonization and validation of an islet-specific AIM assay | Benaroya Research Institute at Virginia Mason | Karen Cerosaletti | Cures | 01-February-2024 to 31-January-2026 | $299.998,00 |
| Evaluation of Oxidized Insulin as a Biomarker and Therapeutic Target in Type 1 Diabetes | Trustees of Indiana University | Amelia Linnemann | Cures | 01-October-2023 to 30-September-2026 | $560.000,00 |
| Immune-checkpoint engineered beta cells as treatment for T1D | UT Southwestern | Andrew Wang | Cures | 01-October-2023 to 30-September-2026 | $746.818,40 |